Investment Trusts

International Biotechnology Trust

IBT:LSE

International Biotechnology Trust

Actions
  • Price (GBX)898.00
  • Today's Change-4.00 / -0.44%
  • Shares traded8.21k
  • 1 Year change+36.47%
  • Beta0.4818
Data delayed at least 20 minutes, as of Mar 04 2026 08:46 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceInternational Biotechnology Trust (Ordinary Share)+38.43%
NAVInternational Biotechnology Trust (Ordinary Share)+40.33%
Morningstar's BenchmarkNasdaq Biotechnology Index--

Key statistics

As of last trade International Biotechnology Trust (IBT:LSE) traded at 898.00, -10.24% below its 52-week high of 1,000.50, set on Dec 15, 2025.
52-week range
Today
480.00Apr 09 20251,000.50Dec 15 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding31.90m
Market cap288.40m GBP
Total assets334.38m GBP
Total expense ratio--
High902.00
Low886.00
Previous close902.00
Average volume44.76k
YTD Change-6.85%
Beta0.4818
Diluted NAV (est)948.71
Diluted NAV (last pub)983.78
Premium/Discount-4.92%
Net Gearing+9.43%
Annual div (ADY)31.81
GBX
Annual div yield (ADY)3.52%
Div ex-dateDec 29 2025
Div pay-dateJan 23 2026
Data delayed at least 20 minutes, as of Mar 04 2026 08:46 GMT.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.